T3‐T4 laryngeal cancer in The Netherlands Cancer Institute; 10‐year results of the consistent application of an organ‐preserving/‐sacrificing protocol

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0347|37|10|1495-1503

ISSN： 1043-3074

Source： HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol.37, Iss.10, 2015-10, pp. : 1495-1503

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Five-year survival after palliative radiotherapy of T4/N3 lung cancer: case series and review of the literature

By  

Journal of Radiotherapy in Practice, Vol. 14, Iss. 1, 2014-08 ,pp. : 102-104

Cambridge University Press

Access to resources Recommend Favorite

The Management of T1G3 Bladder Cancer

By  

Urologia Internationalis, Vol. 69, Iss. 4, 2002-11 ,pp. : 263-265

Karger

Access to resources Recommend Favorite

An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 3, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased CD4+CD25+FOXP3+ Regulatory T Cells in Cancer Patients from Conversion of CD4+CD25– T Cells through Tumor-Derived Factors

By  

Oncology Research and Treatment, Vol. 31, Iss. 5, 2008-04 ,pp. : 243-248

Karger

Access to resources Recommend Favorite

Prognostic Factors and Multidisciplinary Postoperative Chemoradiotherapy for Clinical T4a Tongue Cancer

By  

Oncology, Vol. 91, Iss. 2, 2016-06 ,pp. : 78-84

Karger

Access to resources Recommend Favorite